Characterisation of the protein expression of the emerging immunotherapy targets VISTA, LAG-3 and PRAME in primary uveal melanoma: insights from a southern French patient cohort
Nuno Jorge Lamas(New York Stem Cell Foundation), Paul Hofman(Centre National de la Recherche Scientifique), Olivier Bordone(Centre National de la Recherche Scientifique), Adam Macocco(Université Côte d'Azur), Virginie Lespinet‐Fabre(Centre National de la Recherche Scientifique), Katia Zahaf(Université Côte d'Azur), Stéphanie Baillif(Université Côte d'Azur), Sacha Nahon‐Estève(Université Côte d'Azur), Arnaud Martel(Centre Hospitalier Universitaire de Nice), Salomé Lalvée(Université Côte d'Azur), Florence Pédeutour(Université Côte d'Azur), Sandra Lassalle(Université Côte d'Azur), Julien Fayada(Université Côte d'Azur)
Cited by 10
Related Papers
The Extracellular Signal–Regulated Kinase Isoform ERK1 Is Specifically Required for In Vitro and In Vivo Adipogenesis
|Diabetes|2005|334
Single-cell RNA sequencing reveals intratumoral heterogeneity in primary uveal melanomas and identifies HES6 as a driver of the metastatic disease
|Cell Death and Differentiation|2021|109
Subversion of Autophagy in Adherent Invasive Escherichia coli-Infected Neutrophils Induces Inflammation and Cell Death
|PLoS ONE|2012|67
Prognostic Biomarkers in Uveal Melanoma: The Status Quo, Recent Advances and Future Directions
|Cancers|2021|62
RASMOT-3D PRO: a 3D motif search webserver
|Nucleic Acids Research|2009|57